Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
COMETARY SCIENCE. The nonmagnetic nucleus of comet 67P/Churyumov-Gerasimenko.

Science (New York, N.Y.)

Auster HU, Apathy I, Berghofer G, Fornacon KH, Remizov A, Carr C, Güttler C, Haerendel G, Heinisch P, Hercik D, Hilchenbach M, Kührt E, Magnes W, Motschmann U, Richter I, Russell CT, Przyklenk A, Schwingenschuh K, Sierks H, Glassmeier KH.
PMID: 25873744
Science. 2015 Jul 31;349(6247):aaa5102. doi: 10.1126/science.aaa5102. Epub 2015 Apr 14.

Knowledge of the magnetization of planetary bodies constrains their origin and evolution, as well as the conditions in the solar nebular at that time. On the basis of magnetic field measurements during the descent and subsequent multiple touchdown of...

Cite
Auster HU, Apathy I, Berghofer G, et al. COMETARY SCIENCE. The nonmagnetic nucleus of comet 67P/Churyumov-Gerasimenko. Science. 2015;349(6247):aaa5102doi: 10.1126/science.aaa5102.
Auster, H. U., Apathy, I., Berghofer, G., Fornacon, K. H., Remizov, A., Carr, C., Güttler, C., Haerendel, G., Heinisch, P., Hercik, D., Hilchenbach, M., Kührt, E., Magnes, W., Motschmann, U., Richter, I., Russell, C. T., Przyklenk, A., Schwingenschuh, K., Sierks, H., & Glassmeier, K. H. (2015). COMETARY SCIENCE. The nonmagnetic nucleus of comet 67P/Churyumov-Gerasimenko. Science (New York, N.Y.), 349(6247), aaa5102. https://doi.org/10.1126/science.aaa5102
Auster, Hans-Ulrich, et al. "COMETARY SCIENCE. The nonmagnetic nucleus of comet 67P/Churyumov-Gerasimenko." Science (New York, N.Y.) vol. 349,6247 (2015): aaa5102. doi: https://doi.org/10.1126/science.aaa5102
Auster HU, Apathy I, Berghofer G, Fornacon KH, Remizov A, Carr C, Güttler C, Haerendel G, Heinisch P, Hercik D, Hilchenbach M, Kührt E, Magnes W, Motschmann U, Richter I, Russell CT, Przyklenk A, Schwingenschuh K, Sierks H, Glassmeier KH. COMETARY SCIENCE. The nonmagnetic nucleus of comet 67P/Churyumov-Gerasimenko. Science. 2015 Jul 31;349(6247):aaa5102. doi: 10.1126/science.aaa5102. Epub 2015 Apr 14. PMID: 25873744.
Copy Download .nbib Format: NLM
Lethal Myocardial "Reperfusion Injury": The Opinions of Good Men.

Journal of thrombosis and thrombolysis

Przyklenk K.
PMID: 10639217
J Thromb Thrombolysis. 1997 Jan;4(1):5-6. doi: 10.1023/a:1017549827004.

No abstract available.

Cite
Przyklenk K. Lethal Myocardial "Reperfusion Injury": The Opinions of Good Men. J Thromb Thrombolysis. 1997;4(1):5-6doi: 10.1023/a:1017549827004.
Przyklenk, K. (1997). Lethal Myocardial "Reperfusion Injury": The Opinions of Good Men. Journal of thrombosis and thrombolysis, 4(1), 5-6. https://doi.org/10.1023/a:1017549827004
Przyklenk. "Lethal Myocardial "Reperfusion Injury": The Opinions of Good Men." Journal of thrombosis and thrombolysis vol. 4,1 (1997): 5-6. doi: https://doi.org/10.1023/a:1017549827004
Przyklenk K. Lethal Myocardial "Reperfusion Injury": The Opinions of Good Men. J Thromb Thrombolysis. 1997 Jan;4(1):5-6. doi: 10.1023/a:1017549827004. PMID: 10639217.
Copy Download .nbib Format: NLM
Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial.

Journal of thrombosis and thrombolysis

Kloner RA, Przyklenk K, Shook T, Cannon CP.
PMID: 10751789
J Thromb Thrombolysis. 1998 Sep;6(2):89-92. doi: 10.1023/A:1008833101817.

There has been debate regarding the issue of whether ischemic preconditioning is effective in the aging and diseased heart. Therefore, we retrospectively analyzed the effect of preinfarction angina in patients less than versus greater than 60 years of age...

Cite
Kloner RA, Przyklenk K, Shook T, et al. Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial. J Thromb Thrombolysis. 1998;6(2):89-92doi: 10.1023/A:1008833101817.
Kloner, R. A., Przyklenk, K., Shook, T., & Cannon, C. P. (1998). Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial. Journal of thrombosis and thrombolysis, 6(2), 89-92. https://doi.org/10.1023/A:1008833101817
Kloner, et al. "Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial." Journal of thrombosis and thrombolysis vol. 6,2 (1998): 89-92. doi: https://doi.org/10.1023/A:1008833101817
Kloner RA, Przyklenk K, Shook T, Cannon CP. Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial. J Thromb Thrombolysis. 1998 Sep;6(2):89-92. doi: 10.1023/A:1008833101817. PMID: 10751789.
Copy Download .nbib Format: NLM
Ischemic conditioning: the challenge of protecting the diabetic heart.

Cardiovascular diagnosis and therapy

Wider J, Przyklenk K.
PMID: 25414825
Cardiovasc Diagn Ther. 2014 Oct;4(5):383-96. doi: 10.3978/j.issn.2223-3652.2014.10.05.

The successful clinical translation of novel therapeutic strategies to attenuate lethal myocardial ischemia-reperfusion injury and limit infarct size has been identified as a major unmet need, and is of particular importance in patients with type-2 diabetes. There is a...

Cite
Wider J, Przyklenk K. Ischemic conditioning: the challenge of protecting the diabetic heart. Cardiovasc Diagn Ther. 2014;4(5):383-96doi: 10.3978/j.issn.2223-3652.2014.10.05.
Wider, J., & Przyklenk, K. (2014). Ischemic conditioning: the challenge of protecting the diabetic heart. Cardiovascular diagnosis and therapy, 4(5), 383-96. https://doi.org/10.3978/j.issn.2223-3652.2014.10.05
Wider, Joseph, and Przyklenk, Karin. "Ischemic conditioning: the challenge of protecting the diabetic heart." Cardiovascular diagnosis and therapy vol. 4,5 (2014): 383-96. doi: https://doi.org/10.3978/j.issn.2223-3652.2014.10.05
Wider J, Przyklenk K. Ischemic conditioning: the challenge of protecting the diabetic heart. Cardiovasc Diagn Ther. 2014 Oct;4(5):383-96. doi: 10.3978/j.issn.2223-3652.2014.10.05. PMID: 25414825; PMCID: PMC4221316.
Copy Download .nbib Format: NLM
Time Frame of Ischemic Preconditioning: Is It Clinically Relevant?.

Journal of cardiovascular pharmacology and therapeutics

Birnbaum Y, Przyklenk K, Kloner RA.
PMID: 10684435
J Cardiovasc Pharmacol Ther. 1996 Oct;1(4):339-346. doi: 10.1177/107424849600100410.

No abstract available.

Cite
Birnbaum Y, Przyklenk K, Kloner RA. Time Frame of Ischemic Preconditioning: Is It Clinically Relevant?. J Cardiovasc Pharmacol Ther. 1996;1(4):339-346doi: 10.1177/107424849600100410.
Birnbaum, Y., Przyklenk, K., & Kloner, R. A. (1996). Time Frame of Ischemic Preconditioning: Is It Clinically Relevant?. Journal of cardiovascular pharmacology and therapeutics, 1(4), 339-346. https://doi.org/10.1177/107424849600100410
Birnbaum, et al. "Time Frame of Ischemic Preconditioning: Is It Clinically Relevant?." Journal of cardiovascular pharmacology and therapeutics vol. 1,4 (1996): 339-346. doi: https://doi.org/10.1177/107424849600100410
Birnbaum Y, Przyklenk K, Kloner RA. Time Frame of Ischemic Preconditioning: Is It Clinically Relevant?. J Cardiovasc Pharmacol Ther. 1996 Oct;1(4):339-346. doi: 10.1177/107424849600100410. PMID: 10684435.
Copy Download .nbib Format: NLM
Preconditioning stimuli and inadvertent preconditioning.

Journal of molecular and cellular cardiology

Kloner RA, Przyklenk K, Whittaker P, Hale S.
PMID: 7776379
J Mol Cell Cardiol. 1995 Feb;27(2):743-7. doi: 10.1016/0022-2828(95)90079-9.

There are several factors besides brief episodes of total coronary occlusion which can provide sufficient stress to result in a preconditioning-like effect on the size of a myocardial infarction. Partial coronary artery stenosis, hypoxia, stretch, catecholamines, rapid pacing, and...

Cite
Kloner RA, Przyklenk K, Whittaker P, et al. Preconditioning stimuli and inadvertent preconditioning. J Mol Cell Cardiol. 1995;27(2):743-7doi: 10.1016/0022-2828(95)90079-9.
Kloner, R. A., Przyklenk, K., Whittaker, P., & Hale, S. (1995). Preconditioning stimuli and inadvertent preconditioning. Journal of molecular and cellular cardiology, 27(2), 743-7. https://doi.org/10.1016/0022-2828(95)90079-9
Kloner, R A, et al. "Preconditioning stimuli and inadvertent preconditioning." Journal of molecular and cellular cardiology vol. 27,2 (1995): 743-7. doi: https://doi.org/10.1016/0022-2828(95)90079-9
Kloner RA, Przyklenk K, Whittaker P, Hale S. Preconditioning stimuli and inadvertent preconditioning. J Mol Cell Cardiol. 1995 Feb;27(2):743-7. doi: 10.1016/0022-2828(95)90079-9. PMID: 7776379.
Copy Download .nbib Format: NLM
Early glycemic control in critically ill emergency department patients: pilot trial.

The western journal of emergency medicine

Cohen J, Goedecke E, Cyrkler JE, Mangolds VB, Bateman J, Przyklenk K, Mullen MT.
PMID: 20411069
West J Emerg Med. 2010 Feb;11(1):20-3.

OBJECTIVE: Glycemic control in the critically ill intensive care unit (ICU) patient has been shown to improve morbidity and mortality. We sought to investigate the effect of early glycemic control in critically ill emergency department (ED) patients in a...

Cite
Cohen J, Goedecke E, Cyrkler JE, et al. Early glycemic control in critically ill emergency department patients: pilot trial. West J Emerg Med. 2010;11(1):20-3
Cohen, J., Goedecke, E., Cyrkler, J. E., Mangolds, V. B., Bateman, J., Przyklenk, K., & Mullen, M. T. (2010). Early glycemic control in critically ill emergency department patients: pilot trial. The western journal of emergency medicine, 11(1), 20-3.
Cohen, Jason, et al. "Early glycemic control in critically ill emergency department patients: pilot trial." The western journal of emergency medicine vol. 11,1 (2010): 20-3.
Cohen J, Goedecke E, Cyrkler JE, Mangolds VB, Bateman J, Przyklenk K, Mullen MT. Early glycemic control in critically ill emergency department patients: pilot trial. West J Emerg Med. 2010 Feb;11(1):20-3. PMID: 20411069; PMCID: PMC2850847.
Copy Download .nbib Format: NLM
Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned From ERICCA and RIPHeart.

Circulation research

Garratt KN, Whittaker P, Przyklenk K.
PMID: 27034272
Circ Res. 2016 Apr 01;118(7):1052-4. doi: 10.1161/CIRCRESAHA.115.308102.

No abstract available.

Cite
Garratt KN, Whittaker P, Przyklenk K. Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned From ERICCA and RIPHeart. Circ Res. 2016;118(7):1052-4doi: 10.1161/CIRCRESAHA.115.308102.
Garratt, K. N., Whittaker, P., & Przyklenk, K. (2016). Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned From ERICCA and RIPHeart. Circulation research, 118(7), 1052-4. https://doi.org/10.1161/CIRCRESAHA.115.308102
Garratt, Kirk N, et al. "Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned From ERICCA and RIPHeart." Circulation research vol. 118,7 (2016): 1052-4. doi: https://doi.org/10.1161/CIRCRESAHA.115.308102
Garratt KN, Whittaker P, Przyklenk K. Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned From ERICCA and RIPHeart. Circ Res. 2016 Apr 01;118(7):1052-4. doi: 10.1161/CIRCRESAHA.115.308102. PMID: 27034272.
Copy Download .nbib Format: NLM
Targeted Coronary Thrombolysis via "Pericardial" Administration of Lytic Agents?.

Journal of thrombosis and thrombolysis

Przyklenk K, Hutsell TC, Hata K, Whittaker P.
PMID: 10751788
J Thromb Thrombolysis. 1998 Sep;6(2):83-88. doi: 10.1023/A:1008870700908.

No abstract available.

Cite
Przyklenk K, Hutsell TC, Hata K, et al. Targeted Coronary Thrombolysis via "Pericardial" Administration of Lytic Agents?. J Thromb Thrombolysis. 1998;6(2):83-88doi: 10.1023/A:1008870700908.
Przyklenk, K., Hutsell, T. C., Hata, K., & Whittaker, P. (1998). Targeted Coronary Thrombolysis via "Pericardial" Administration of Lytic Agents?. Journal of thrombosis and thrombolysis, 6(2), 83-88. https://doi.org/10.1023/A:1008870700908
Przyklenk, et al. "Targeted Coronary Thrombolysis via "Pericardial" Administration of Lytic Agents?." Journal of thrombosis and thrombolysis vol. 6,2 (1998): 83-88. doi: https://doi.org/10.1023/A:1008870700908
Przyklenk K, Hutsell TC, Hata K, Whittaker P. Targeted Coronary Thrombolysis via "Pericardial" Administration of Lytic Agents?. J Thromb Thrombolysis. 1998 Sep;6(2):83-88. doi: 10.1023/A:1008870700908. PMID: 10751788.
Copy Download .nbib Format: NLM
Cardioprotection with sodium-hydrogen exchange inhibition: An archetype of "Bench to bedside" .

Journal of thrombosis and thrombolysis

Przyklenk K.
PMID: 10481207
J Thromb Thrombolysis. 1999 Jul;8(1):5-6. doi: 10.1023/A:1008902911288.

No abstract available.

Cite
Przyklenk K. Cardioprotection with sodium-hydrogen exchange inhibition: An archetype of "Bench to bedside" . J Thromb Thrombolysis. 1999;8(1):5-6doi: 10.1023/A:1008902911288.
Przyklenk, K. (1999). Cardioprotection with sodium-hydrogen exchange inhibition: An archetype of "Bench to bedside" . Journal of thrombosis and thrombolysis, 8(1), 5-6. https://doi.org/10.1023/A:1008902911288
Przyklenk. "Cardioprotection with sodium-hydrogen exchange inhibition: An archetype of "Bench to bedside" ." Journal of thrombosis and thrombolysis vol. 8,1 (1999): 5-6. doi: https://doi.org/10.1023/A:1008902911288
Przyklenk K. Cardioprotection with sodium-hydrogen exchange inhibition: An archetype of "Bench to bedside" . J Thromb Thrombolysis. 1999 Jul;8(1):5-6. doi: 10.1023/A:1008902911288. PMID: 10481207.
Copy Download .nbib Format: NLM
From ischemic conditioning to 'hyperconditioning': clinical phenomenon and basic science opportunity.

Dose-response : a publication of International Hormesis Society

Whittaker P, Przyklenk K.
PMID: 25552962
Dose Response. 2014 Oct 20;12(4):650-63. doi: 10.2203/dose-response.14-035.Whittaker. eCollection 2014 Dec.

Thousands of articles have been published on the topic of ischemic conditioning. Nevertheless, relatively little attention has been given to assessment of conditioning's dose-response characteristics. Specifically, the consequences of multiple conditioning episodes, what we will term "hyperconditioning", have seldom...

Cite
Whittaker P, Przyklenk K. From ischemic conditioning to 'hyperconditioning': clinical phenomenon and basic science opportunity. Dose Response. 2014;12(4):650-63doi: 10.2203/dose-response.14-035.Whittaker.
Whittaker, P., & Przyklenk, K. (2014). From ischemic conditioning to 'hyperconditioning': clinical phenomenon and basic science opportunity. Dose-response : a publication of International Hormesis Society, 12(4), 650-63. https://doi.org/10.2203/dose-response.14-035.Whittaker
Whittaker, Peter, and Przyklenk, Karin. "From ischemic conditioning to 'hyperconditioning': clinical phenomenon and basic science opportunity." Dose-response : a publication of International Hormesis Society vol. 12,4 (2014): 650-63. doi: https://doi.org/10.2203/dose-response.14-035.Whittaker
Whittaker P, Przyklenk K. From ischemic conditioning to 'hyperconditioning': clinical phenomenon and basic science opportunity. Dose Response. 2014 Oct 20;12(4):650-63. doi: 10.2203/dose-response.14-035.Whittaker. eCollection 2014 Dec. PMID: 25552962; PMCID: PMC4267454.
Copy Download .nbib Format: NLM
Publisher Correction: Inhibitory modulation of cytochrome c oxidase activity with specific near-infrared light wavelengths attenuates brain ischemia/reperfusion injury.

Scientific reports

Sanderson TH, Wider JM, Lee I, Reynolds CA, Liu J, Lepore B, Tousignant R, Bukowski MJ, Johnston H, Fite A, Raghunayakula S, Kamholz J, Grossman LI, Przyklenk K, Hüttemann M.
PMID: 29695825
Sci Rep. 2018 Apr 25;8(1):6729. doi: 10.1038/s41598-018-25184-3.

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Cite
Sanderson TH, Wider JM, Lee I, et al. Publisher Correction: Inhibitory modulation of cytochrome c oxidase activity with specific near-infrared light wavelengths attenuates brain ischemia/reperfusion injury. Sci Rep. 2018;8(1):6729doi: 10.1038/s41598-018-25184-3.
Sanderson, T. H., Wider, J. M., Lee, I., Reynolds, C. A., Liu, J., Lepore, B., Tousignant, R., Bukowski, M. J., Johnston, H., Fite, A., Raghunayakula, S., Kamholz, J., Grossman, L. I., Przyklenk, K., & Hüttemann, M. (2018). Publisher Correction: Inhibitory modulation of cytochrome c oxidase activity with specific near-infrared light wavelengths attenuates brain ischemia/reperfusion injury. Scientific reports, 8(1), 6729. https://doi.org/10.1038/s41598-018-25184-3
Sanderson, Thomas H, et al. "Publisher Correction: Inhibitory modulation of cytochrome c oxidase activity with specific near-infrared light wavelengths attenuates brain ischemia/reperfusion injury." Scientific reports vol. 8,1 (2018): 6729. doi: https://doi.org/10.1038/s41598-018-25184-3
Sanderson TH, Wider JM, Lee I, Reynolds CA, Liu J, Lepore B, Tousignant R, Bukowski MJ, Johnston H, Fite A, Raghunayakula S, Kamholz J, Grossman LI, Przyklenk K, Hüttemann M. Publisher Correction: Inhibitory modulation of cytochrome c oxidase activity with specific near-infrared light wavelengths attenuates brain ischemia/reperfusion injury. Sci Rep. 2018 Apr 25;8(1):6729. doi: 10.1038/s41598-018-25184-3. PMID: 29695825; PMCID: PMC5916910.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries